Fredun Pharmaceuticals Limited (BOM:539730)
India
· Delayed Price · Currency is INR 728.95
-1.65 (-0.23%)
At close: Jun 6, 2025
Fredun Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Fredun Pharmaceuticals had annual revenue of 4.56B INR with 31.05% growth. Fredun Pharmaceuticals had revenue of 1.67B in the quarter ending March 31, 2025, with 42.82% growth.
Revenue
4.56B
Revenue Growth
+31.05%
P/S Ratio
0.75
Revenue / Employee
17.82M
Employees
256
Market Cap
3.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.56B | 1.08B | 31.05% |
| Mar 31, 2024 | 3.48B | 734.81M | 26.75% |
| Mar 31, 2023 | 2.75B | 502.16M | 22.37% |
| Mar 31, 2022 | 2.24B | 906.43M | 67.74% |
| Mar 31, 2021 | 1.34B | 211.22M | 18.74% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Fredun Pharmaceuticals News
- 6 months ago - Fredun Pharmaceuticals stock jumps 3% after company set to launch advanced functional foods plant - Business Upturn